RightFit
RecruitingNot applicable

Dietary Insights and Nutritional Education in Adults on GLP-1 Therapy

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
18 Years to 65 Years
Sex
All sexes
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

  • Procedures mentioned: Interviews

Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.

Show the study's own words
  • "Participants will complete baseline assessments, receive a 6-week app-based nutrition intervention consisting of daily dietary self-monitoring and weekly learning modules, and complete follow-up assessments and a structured interview."
Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This small study tests whether the SWITCH nutrition app is practical, easy to accept, and helpful to adults taking GLP-1 medicines for obesity or type 2 diabetes. For 6 weeks, participants will track their food each day and complete weekly lessons. They will also complete checks before and after using the app and take part in an interview.

This pilot study will evaluate the feasibility, acceptability, and perceived usefulness of the SWITCH mobile nutrition behavioral intervention among adults receiving GLP-1 receptor agonist therapy for obesity and/or type 2 diabetes. Participants will complete baseline assessments, receive a 6-week app-based nutrition intervention consisting of daily dietary self-monitoring and weekly learning modules, and complete follow-up assessments and a structured interview.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Be 18 to 65 years old.
  • Have a BMI of 30 to 49.9, type 2 diabetes, or both. BMI is a measure of weight compared with height.
  • Have a prescription for a GLP-1 medicine and have used it for at least 4 weeks.
  • Own an Android or Apple smartphone with an active data plan.
  • Live in the United States.
  • Be willing and able to eat fewer calories.
  • Have no major physical or mental health conditions or drug or alcohol dependence.
  • Be willing to sign a form agreeing to join the study.

Who can't join

  • Have type 1 diabetes or severe diabetes problems, such as serious eye or nerve damage, kidney disease needing dialysis (a treatment that filters blood), or open foot sores. A hospital stay for dangerous blood sugar problems in the past 6 months also rules you out.
  • Be in another structured weight-loss program or study now, or within the past 6 months, that could affect this study's results; or currently use another experimental weight-loss device or medicine.
  • Be pregnant, breastfeeding, or planning to become pregnant during the study.
  • Have a diagnosed eating disorder or another mental health condition that study staff believe could make it hard to follow the program.
  • Have severe heart, liver, kidney, or lung disease that limits moderate exercise or changes in eating habits.
  • Have received cancer treatment, such as chemotherapy, radiation, or surgery, within the past 12 months; or have had a drug use disorder or alcohol dependence during that time.
  • Have trouble with thinking or memory, or another health condition, that makes it hard to understand or follow study steps.
  • Lack reliable internet or smartphone access, or be unwilling to use an app for tracking and communication.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: * • Age between 18 and 65 years. * BMI between 30 - 49.9 kg/m2 and/or diagnosed with type 2 diabetes. * Currently prescribed and using GLP-1 receptor therapy for at least 4 weeks. * Own a smartphone (Android or iOS) with an active data plan to support app-based intervention delivery. * Residing anywhere in the United States. * Must be willing and able to reduce caloric intake. * Be free of major health or psychiatric diseases, drug, or alcohol dependency. * Willing to sign informed consent. Exclusion Criteria: * • Presence of type 1 diabetes mellitus * Severe complications, including but not limited to proliferative retinopathy, severe peripheral neuropathy, nephropathy requiring dialysis, active foot ulcers, or recent hospitalization for diabetic ketoacidosis or hyperosmolar hyperglycemic state within the past 6 months. * Current or recent (within 6 months) participation in another structured weight loss program or clinical trial that may interfere with study outcomes. * Pregnancy, breastfeeding, or plans to become pregnant during the study period. * Current use of another investigational weight loss device or medication. * Diagnosed eating disorders (e.g., anorexia nervosa, bulimia nervosa, binge eating disorder) or other psychiatric conditions that may affect adherence to behavioral interventions, as determined by study staff. * Severe cardiovascular, hepatic, renal, or pulmonary disease that would limit participation in moderate physical activity or dietary modification. * Active cancer treatment (chemotherapy, radiation, or surgery) within the past 12 months. * Substance use disorder or alcohol dependency within the past 12 months. * Cognitive impairment or any medical or mental condition that would interfere with the ability to understand or comply with study procedures. * Lack of reliable internet or smartphone access, or unwillingness to use a mobile app for tracking and communication.

Study sites (1)

SC